The Department of Health and Human Services (HHS) announced the second group of high-cost prescription drugs chosen for Medicare price [...] …
Blog Posts
Q: Tell us some interesting details about your company’s history.
At CPS Solutions, LLC (CPS), we’ve been supporting healthcare organizations to transform pharmacy results for over 50 years.
CPS’ 800+ healthcare
…
Novartis this week became the fifth manufacturer to sue the Health Resources and Services Administration (HRSA) to implement a 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Yesterday’s New York Times investigative article alleging that the 340B prime vendor, Apexus, profited by driving 340B program expansion has [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Lawmakers in Nebraska and New York have reintroduced 340B contract pharmacy access bills this week after their state legislatures failed [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The House Energy and Commerce (E&C) Committee, which has jurisdiction over the 340B and Medicaid programs, held its first meeting [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmakers Bristol Myers Squibb (BMS) and Vertex have each announced changes to their 340B contract pharmacy restrictions that apply to [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Participation in the 340B program did not increase the number of vulnerable patients beginning targeted care for prostate cancer, a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Congress could pursue 340B program reform and spending cuts—along with other major health policy changes—as part of an expected budget [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The chairperson of a political action committee with multiple links to a conservative dark money group that ran controversial ads [...] …